NCPA's qAM

qAM

NCPA leaders attend White House bill signing

by NCPA | Oct 11, 2018

At a ceremony in the Roosevelt Room, four NCPA leaders joined President Trump as he signed legislation prohibiting so-called pharmacy "gag clauses" that may result in patients being charged inflated prices for their medications. Attending along with NCPA CEO Doug Hoey were newly-installed president Bill Osborn, PharmD, owner of Osborn Drugs in Miami, Okla.; and board members Michele M. Belcher, RPh, owner of Grants Pass Pharmacy in Grants Pass, Ore., and Hugh M. Chancy, RPh, owner of Chancy Drugs in Hahira, Ga.

The president signed S. 2553, the Know the Lowest Price Act of 2018, and S. 2554, the Patient Right to Know Drug Prices Act, which give community pharmacists more flexibility in informing patients they could pay less out of pocket for a prescription than by using their health insurance. NCPA recently sent a letter to President Trump – and a number of community pharmacy champions, including those who sponsored and led the legislation – urging that he sign them into law.

Drug prices "are way out of whack," Trump said in remarks before he signed the bills. "They're way too high." HHS Secretary Alex Azar agreed. "There is significant consensus. We all want to get drug prices down," he said. "This is just the tip of the iceberg."

"We have middleman problems," Trump also said. We think so too.



See tomorrow's Executive Update for more on the bill signing ceremony and how it all came together.